Acute pain occurring in the early postoperative period after elective laparoscopic cholecystectomy, requiring postoperative analgesia.. Pain, unspecified
Conditions
Interventions
Intervention 1: Intervention group: After induction of general anesthesia and before surgical incision, participants receive an ultrasound guided transversus abdominis plane block. A total of 20 milli
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: ASA class I & II Informed consent to participate in the project BMI between 18 and 35
Exclusion criteria
Exclusion criteria: Allergy to anesthetic drugs used in the plan failure of the chosen method Patient's unwillingness to participate in the plan Localized sepsis at the site of the block Alcohol or drug abuse History of any coagulation disorder Surgery time more than 3 hours Surgeries in which the patient experiences surgical complications during the operation for any reason Any mental or psychological disorder History of serious painful illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain intensity at rest. Timepoint: 2, 6, 12, and 24 hours after surgery. Method of measurement: Visual analogue scale, a 10 centimetre line anchored by no pain and worst imaginable pain.;Cumulative intravenous morphine dose administered during the first 24 hours after surgery. Timepoint: From the end of surgery to 24 hours after surgery. Method of measurement: Total intravenous morphine dose extracted from the medication administration record and patient chart. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total intravenous fentanyl dose administered intraoperatively. Timepoint: At the end of surgery, as the cumulative dose from induction of anesthesia to the end of surgery. Method of measurement: Total intravenous fentanyl dose extracted from the anesthesia record and intraoperative medication chart.;Need for intravenous ketorolac administration in the post anesthesia care unit. Timepoint: During the post anesthesia care unit stay, from admission to discharge. Method of measurement: Documentation of intravenous ketorolac administration in the post anesthesia care unit medication administration record.;Incidence of block related complications. Timepoint: During block performance and up to 24 hours after surgery. Method of measurement: Clinical assessment and documentation of adverse events including injection site hematoma or bleeding, signs of local infection, signs of local anesthetic systemic toxicity, and any other reported adverse events. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBabak Eslami
Tehran University of Medical Sciences
Outcome results
None listed